Download INFORMTM HER2 - HER

Transcript
Method 2A: Additional Quantitative
in both target areas (40 cells) by the total number of
For cases that have been enumerated using Method 2
Chr17 signals in both target areas (40 cells). Results are
and have a HER2/Chr17 ratio either equal to or between
reported as:
1.8 and 2.2, Method 2A must be utilized. The reader
a. N
egative for HER2 gene amplification. Defined as a
HER2/Chr17 ratio less than 1.8.
selects a second target area for each of HER2 and Chr17
b. E
quivocal for HER2 gene amplification. Defined as a
and counts the number of signals in 20 additional nuclei.
The HER2/Chr17 ratio using counts from both target
HER2/Chr17 ratio equal to or between 1.8 and 2.2.
areas is then calculated. A total of 40 nuclei will have
c. P
ositive for HER2 gene amplification. Defined as a
HER2 Chr17 ratio greater than 2.2.
been read between both target areas. Calculate the HER2/
Chr17 ratio by dividing the total number of HER2 signals
Figure 11. Method 2A Scoring Algorithm
1.8
HER2/Chr17 Ratio
1.0
2.2
3.0
2.0
Negative for HER2 Gene Amplification Equivocal
5.0
6.0
Positive for HER2 Gene Amplification
Method 2A
Start
Method 2A
HER2 stained
slide
Identify and select target area 2
Count HER2 signals in 20 nuceli
Chr17
stained slide
Locate target area 2.
Count Chr17 signals in 20 nuceli.
Calculate HER2/Chr17 ratio by dividing
the total number of HER2 signals from
target area 1 and 2 by the total number
of Chr17 signals fron target area 1 and 2
Report Results
Negative
HER2/Chr17 < 1.8
Equivocal
1.8 ≤ HER2/Chr17 ≤ 2.2
Positive
HER2/Chr17 > 2.2
800 227 2155
www.ventanamed.com 11